Low/Intermediate PCa Video Chat, March 23, 2026

Low/Intermediate PCa Video Chat, March 23, 2026

by | Apr 7, 2026 | Cancer Caregivers, Cancer Resources, Low/Intermediate Prostate Cancer, Recorded Groups

Low/Intermediate PCa Video Chat, March 23, 2026

Low/Intermediate PCa Video Chat, March 23, 2026

AnCan is grateful to the following sponsors for making this recording possible: Novartis, Telix, Blue Earth Diagnostics, and Foundation Medicine.

WELCOME all to our newly recorded Low/Intermediate Prostate Cancer Group. To receive notice when new recordings are posted, either follow us on this YouTube Channel or sign up to our Blog via https://ancan.org/contact-us/ – check New Blog box.

Join our other free and drop in groups:
AnCan respectfully notes that it does not accept sponsored promotion. Any drugs, protocols or devices recommended in our discussions are based solely on anecdotal peer experience or clinical evidence.
AnCan cannot and does not provide medical advice. We encourage you to discuss anything you hear in our sessions with your own medical team.
AnCan reminds all Participants that Adverse Events experienced from prescribed drugs or protocols should be reported to the pharmaceutical manufacturer or the FDA Adverse Event Reporting System (FAERS). To do so call 1-800-332-1066 or download interactive FDA Form 3500 https://www.fda.gov/media/76299/download
AnCan’s Prostate Cancer Forum is back (https://ancan.org/forums). If you’d like to comment on anything you see in our Recordings or read in our Reminders, just sign up and go right ahead. You can also click on the Forum icon at the top right of the webpage.
All AnCan’s groups are free and drop-in … join us in person sometime!

Editor’s Pick: High Dose Rate (HDR) brachytherapy versus stereotactic body radiotherapy (SBRT). (bj)

Topics Discussed
Importance of getting a second opinion on bioposy results; clincal study comparison of High Dose Rate (HDR) brachytherapy versus stereotactic body radiotherapy (SBRT); necessity of getting a second opinion on bioposy results for a Gleason 3+3 diagnosis; efficacy of specific supplements and dietary changes in reducing future prostate cancer risk and managing PSA levels.

Chat

Stuart sent a chat · 7:41 PM
Dr. Ming Zhou Mount Sinai Health System Department of Pathology, Box 1194 Annenberg Bldg. 15th FL 1468 Madison Ave New York, NY 10029 Email: Ming.zhou@mountsinai.org Telephone: (212)241-8881

Stuart sent a chat · 7:42 PM
Dr. Jonathan Epstein – https://advanceduropathology.com/  Tel:516-760-2037    jepstein@imppllc.com

Steve in Malaysia sent a chat · 8:49 PM
Hi guys, can you add me? Have a few questions.

Bill Franklin sent a chat · 8:51 PM
We should have plenty of time Steve.

Steve in Malaysia sent a chat · 8:51 PM
Thanks

Bill Franklin sent a chat · 9:08 PM
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2845485

Bill Franklin sent a chat · 9:09 PM
I think this is the one you’re talking about?  Just published in JAMA in Feb, 2026.

Bill Franklin sent a chat · 9:10 PM
JAMA HDR vs SBRT study https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2845485

Bill Franklin sent a chat · 9:10 PM
Rick and I had the same one.

Albert sent a chat · 9:16 PM
Thanks guys

AnCan – Rick sent a chat · 9:27 PM
https://themarsh.org/soloartsheal   Greg Burns  this Wednesday at 7.30 pm PACIFIC

Terri Richards sent a chat · 9:29 PM
Thank You So much Rick, My mic was not working > Thank you for all that you all do !

Ron Jr sent a chat · 9:30 PM
I forgot to ask:  Should I get a 2nd opinion on my Biopsy diagnosis of my GL 3+3 lesion? (or feel lucky about it, and sit down and be grateful)  Additionally, are there proven supplements or dietary changes that can reduce my future Prostate Cancer risk & PSA test numbers?

PCPEP – The Prostate Cancer Patient Empowerment Program: Improve Your Quality of Life

by | Apr 2, 2026 | Active Surveillance PCa, High Risk/Recurrent/Advanced Prostate Cancer, Low/Intermediate Prostate Cancer, Prostate Cancer

PCPEP – The Prostate Cancer Patient Empowerment Program: Improve Your Quality of Life

 

 

PCPEP – learn how to employ the Science and Practice of an Anti‑Inflammatory Lifestyle – With Dr. Rob Rutledge

AnCan is all about survivorship – improving Quality of Life after diagnosis, with a focus on diet/nutrition, exercise, stress management, and more.

We now welcome PCPEP (Prostate Cancer Patient Empowerment Program), a Canadian-based program at Dalhousie University in Halifax, Nova Scotia. https://pcpep.org to our AnCan family.

PCPEP’s goal is to optimize survivorship for prostate cancer patients and others. It does this through daily emails and videos focused on components that contribute to your QoL – exercise, nutrition, stress reduction, and the social connection that makes AnCan a big family.

Watch Co-founder Dr. Rob Rutledge, a GU radiation oncologist, explain the program.

The program is FREE and currently open to ALL men with a prostate cancer diagnosis. Although the presentation was made to Gents in early Active Surveillance, it is open to all levels.

To find a copy of the slides, click here.

AnCan thanks our Sponsors – Novartis, Blue Earth, Telix, and Foundation Medicine

AnCan Keynote at Houston Methodist, Aug 2024 – Can you hear us? Amplifying the patient voice.

AnCan Keynote at Houston Methodist, Aug 2024 – Can you hear us? Amplifying the patient voice.

by | Mar 25, 2026 | Advocacy, Blood Cancers, Cancer Caregivers, Cancer Resources, High Risk/Recurrent/Advanced Prostate Cancer, Low/Intermediate Prostate Cancer, MedaFit, Men 'Speaking Freely', Multiple Sclerosis, Ovarian Cancer, Pancreatic Cancer, Prostate Cancer, Uncategorized, Visual Snow Syndrome, Webinars

AnCan Keynote at Houston Methodist, Aug 2024 – Can you hear us? Amplifying the patient voice.

Can You Hear Us??       How AnCan helps patients make their voice heard – amplifying the patient voice!
Rick Davis gives keynote address at Houston Methodist Neal Cancer Center 12th Annual Cancer Symposium. August 2024.
Click  https://youtu.be/wCQlHIzKoA0-
European Prostate Cancer Virtual Support Group, March 18, 2026

European Prostate Cancer Virtual Support Group, March 18, 2026

by | Mar 19, 2026 | Active Surveillance PCa, High Risk/Recurrent/Advanced Prostate Cancer, Low/Intermediate Prostate Cancer, Prostate Cancer, Recorded Groups, Uncategorized

European Prostate Cancer Virtual Support Group, March 18, 2026

Our European AnCan audience, who find it tough to attend meetings at late hours of the night, have requested a meeting at a more time-friendly hour. Unlike our other prostate groups, this meeting is open to all levels until there is a quorum to establish separate groups for different levels of prostate cancer. The meeting will start with the lowest grade, allowing men to drop out along the way.

This peer-led, free, and drop-in meeting is open to patients and care partners and will be conducted in English. It is open to all; however, Euro-based participants are given priority. This group is held on the 3rd Wednesday of each month at 2 pm Eastern/ 8 pm CET in The Barniskis Room (222-583-973) https://ancan.org/barniskis Sign up to receive a Reminder at https://ancan.org/contact-us

AnCan thanks the following sponsors for making this recording possible: Novartis, Telix, Blue Earth Diagnostics and Foundation Medicine.
Views expressed in this Recording are solely the opinion of AnCan Foundation, our Moderators and Participants.

AnCan does not accept sponsored promotion. Any drugs, protocols or devices discussed are based solely on anecdotal peer experience or clinical evidence.
AnCan cannot and does not provide medical advice. We encourage you to discuss anything you hear in our sessions with your own medical team.

AnCan reminds all Participants that Adverse Events experienced from prescribed drugs or protocols should be reported to the pharmaceutical manufacturer or the FDA Adverse Event Reporting System (FAERS). To do so call 1-800-332-1066 or download interactive FDA Form 3500 https://www.fda.gov/media/76299/download

All AnCan’s groups are free and drop-in … join us in person sometime! You can find out more about our 12 monthly prostate cancer meetings at https://ancan.org/prostate-cancer/ Sign up to receive a weekly Reminder/Newsletter for this Group or others at https://ancan.org/contact-us/

Join our other free and drop in groups:
Men (Only) Speaking Freely…1st & 3rd Thursdays @ 8.00 pm Eastern https://ancan.org/men-speaking-freely/
Veterans Healthcare Navigation… 1st & 3rd Tuesdays @ 8.00 pm Eastern Schmier Room https://ancan.org/veterans/
Veterans Speaking freely… 4th Tuesday @ @ 8.00 pm Eastern Schmier Room

Listen to our recent Estradiol discussion https://ancan.org/learn-from-ancans-emperors-of-estradiol-021626/

Recent article on AnCan in Rarity life. https://ancan.org/rarity-life-magazine-featuring-rick-davis/

Hear Founder, rick davis talk about how AnCan came to be in this 20-min podcast dropped this week on Empowered Patient Radio http://empoweredpatientradio.com/virtual-support-groups-remove-barriers-encourage-sharing-honest-experiences-to-fight-misinformation-with-rick-davis-ancan

Editor’s Pick: Is 5 years on enzalutamide without a change too long?

 

Topics Discussed

Recurrence well handled by a trial immunotherapy in Germany… or was it the radiation therapy; HT French style gives little wiggle room; surgery coming up fast at Martini to address advanced diagnosis; HT is working for Brit – BUT does it need changing up?; hyperbaric treatment in Eire to address RT cystitis

Chat

Low/Intermediate PCa Video Chat, March 23, 2026

Low/Intermediate PCa Video Chat, March 9, 2026

by | Mar 11, 2026 | Cancer Caregivers, Cancer Resources, Low/Intermediate Prostate Cancer, Recorded Groups

Low/Intermediate PCa Video Chat, March 9, 2026

Low/Intermediate PCa Video Chat, March 9, 2026

AnCan is grateful to the following sponsors for making this recording possible: Novartis, Telix, Blue Earth Diagnostics, and Foundation Medicine.

WELCOME all to our newly recorded Low/Intermediate Prostate Cancer Group. To receive notice when new recordings are posted, either follow us on this YouTube Channel or sign up to our Blog via https://ancan.org/contact-us/ – check New Blog box.

Join our other free and drop in groups:
AnCan respectfully notes that it does not accept sponsored promotion. Any drugs, protocols or devices recommended in our discussions are based solely on anecdotal peer experience or clinical evidence.
AnCan cannot and does not provide medical advice. We encourage you to discuss anything you hear in our sessions with your own medical team.
AnCan reminds all Participants that Adverse Events experienced from prescribed drugs or protocols should be reported to the pharmaceutical manufacturer or the FDA Adverse Event Reporting System (FAERS). To do so call 1-800-332-1066 or download interactive FDA Form 3500 https://www.fda.gov/media/76299/download
AnCan’s Prostate Cancer Forum is back (https://ancan.org/forums). If you’d like to comment on anything you see in our Recordings or read in our Reminders, just sign up and go right ahead. You can also click on the Forum icon at the top right of the webpage.
All AnCan’s groups are free and drop-in … join us in person sometime!

Editor’s Pick: The value of connecting with other AnCan peers to compare doctor recommendations and treatment experiences. (bj)

Topics Discussed
Management of Benign Prostatic Hyperplasia (BPH) and prostate size; comparison of radiation modalities such as stereotactic body radiation therapy (SBRT), intensity-modulated radiation therapy (IMRT), magnetic resonance-guided linear accelerator (MRI-Linac) and brachytherapy; comparison of androgen deprivation therapy (ADT) medications: Orgovyx vs Lupron; importance of genomic tests like Decipher, Prolaris, Artera AI, and the PROMISE study (germline testing); discussion on surgical options and surgeon recommendations;  advantages of transperineal over transrectal biopsies; benefits of MRI-fusion biopsies for targeted sampling; veterans get medical treatments through Veterans Affairs (VA) can use Community Care to get access to specialized medical care outside the VA; lymph node involvement seen in a PSMA scan changes disease categorization and requires more advanced drugs; importance of consulting a cardio-oncologist when adding ADT treatments for prostate cancer while recovering from heart surgery; discussion between how long a low/intermediate prostate cancer patient can wait between a diagnosis requiring an active treatment (such as prostatectomy, radiation, hormone therapy) and starting active treatment;  the value of connecting with other AnCan peers at similar stages of their journey to compare doctor recommendations and treatment experiences.

Chat

Stuart sent a chat · 8:01 PM
Dr. Ming Zhou Mount Sinai Health System Department of Pathology, Box 1194 Annenberg Bldg. 15th FL 1468 Madison Ave New York, NY 10029 Email: Ming.zhou@mountsinai.org Telephone: (212)241-8881

Stuart sent a chat · 8:02 PM
Dr. Jonathan Epstein – https://advanceduropathology.com/  Tel:516-760-2037    jepstein@imppllc.com

Bob in Georgia sent a chat · 8:34 PM
can you put those doctor name and contacts in the chat?

AnCan – Rick sent a chat · 8:40 PM
Eggener https://www.uclahealth.org/providers/scott-eggener

AnCan – Rick sent a chat · 8:41 PM
Kishan  UCLA  https://www.uclahealth.org/providers/amar-kishan

AnCan – Rick sent a chat · 8:41 PM
Eggener is UCLA

David in Portland, OR sent a chat · 8:43 PM
Paper on delaying treatment (Mack Roach is co-author): “Delayed Definitive Management of Localized Prostate Cancer: What Do We Know?” Prostate Cancer and Prostate Diseases, Aug. 2024, https://www.nature.com/articles/s41391-024-00876-2

Larry S – ADT by estradiol sent a chat · 8:46 PM
Get baselines for lyour 1) Bone density 2) Hormone levels (especially testosterone) 3) your muscle strength and lean to fat ratio.  These can change with ADT and (in my opinion) you want keep track.

AnCan – Rick sent a chat · 8:48 PM
Brisbane – surgeon  UCLA https://www.uclahealth.org/providers/wayne-brisbane

AnCan – Rick sent a chat · 8:49 PM
Peter Carroll – surgeon UCSF  https://urology.ucsf.edu/people/peter-r-carroll

AnCan – Rick sent a chat · 8:50 PM
Matt Cooperberg  surgeon UCSF  https://urology.ucsf.edu/people/cooperberg

AnCan – Rick sent a chat · 8:50 PM
Mack Roach rad onc UCSF  https://www.ucsfhealth.org/mack.roach

Larry S – ADT by estradiol sent a chat · 8:53 PM
Talk to your doctors about the side effects of ADT, especially if you will be using it for very long.

AnCan – Rick sent a chat · 9:11 PM
Bob…  MRLinac at MSKCC Dr. Nagar

Mark WV sent a chat · 9:27 PM
good night

AnCan – Boykin sent a chat · 9:28 PM
good night

Steve in Malaysia sent a chat · 9:32 PM
Was wondering if I can ask a question or 2.

AnCan – Boykin sent a chat · 9:32 PM
Steve I have you on the list…you’re last

Steve in Malaysia sent a chat · 9:32 PM
Thanks 🙂

Steve K sent a chat · 10:01 PM
Good night. Thanks everyone.

AnCan – Boykin sent a chat · 10:01 PM
Good night Steve K

Larry S – ADT by estradiol sent a chat · 10:03 PM
Cannot stay.  Good night.

AnCan – Boykin sent a chat · 10:03 PM
Good night Larry S

AnCan – Rick sent a chat · 10:06 PM
SBRT vs HDR https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2845485?utm_source=email&utm_campaign=content-shareicons&utm_content=article_engagement&utm_medium=social&utm_term=022826

Low/Intermediate PCa Video Chat, March 23, 2026

Low/Intermediate PCa Video Chat, February 23, 2026

by | Mar 5, 2026 | Cancer Caregivers, Cancer Resources, Low/Intermediate Prostate Cancer, Recorded Groups

Low/Intermediate PCa Video Chat, February 23, 2026

Low/Intermediate PCa Video Chat, February 23, 2026

AnCan is grateful to the following sponsors for making this recording possible: Novartis, Telix, Blue Earth Diagnostics, and Foundation Medicine.

WELCOME all to our newly recorded Low/Intermediate Prostate Cancer Group. To receive notice when new recordings are posted, either follow us on this YouTube Channel or sign up to our Blog via https://ancan.org/contact-us/ – check New Blog box.

Join our other free and drop in groups:
AnCan respectfully notes that it does not accept sponsored promotion. Any drugs, protocols or devices recommended in our discussions are based solely on anecdotal peer experience or clinical evidence.
AnCan cannot and does not provide medical advice. We encourage you to discuss anything you hear in our sessions with your own medical team.
AnCan reminds all Participants that Adverse Events experienced from prescribed drugs or protocols should be reported to the pharmaceutical manufacturer or the FDA Adverse Event Reporting System (FAERS). To do so call 1-800-332-1066 or download interactive FDA Form 3500 https://www.fda.gov/media/76299/download
AnCan’s Prostate Cancer Forum is back (https://ancan.org/forums). If you’d like to comment on anything you see in our Recordings or read in our Reminders, just sign up and go right ahead. You can also click on the Forum icon at the top right of the webpage.
All AnCan’s groups are free and drop-in … join us in person sometime!

Editor’s Pick: Addressing the unusual: Low PSA with high-grade prostate cancer. (bj)

Topics Discussed
Importance of getting a second reading/opinion on your prostate cancer biopsy results; addressing the unusual: low PSA with high-grade prostate cancer; identifying risk factors that can push you from intermediate-risk to high risk prostate cancer; understanding how gentic testing help determine the best treatment options, espcially when family history exists; evaluating high-dose rate (HDR) brachytherapy as a primary treatment or boost to radiation; comparing transperineal and transrectal biopsies with a focus on lower risk infection and better patient experiences; determining when a patient should move from active surveillence (AS) based on rising PSA or new biospy results.

Chat

AnCan – Stuart sent a chat · 7:58 PM
Dr. Ming Zhou Mount Sinai Health System Department of Pathology, Box 1194 Annenberg Bldg. 15th FL 1468 Madison Ave New York, NY 10029 Email: Ming.zhou@mountsinai.org Telephone: (212)241-8881

AnCan – Stuart sent a chat · 7:59 PM
Dr. Jonathan Epstein – https://advanceduropathology.com/  Tel:516-760-2037    jepstein@imppllc.com

AnCan – Rick sent a chat · 8:04 PM
AnCan’s GU ASCO Poster released today   https://ancan.org/ancan-gu-asco26-survivorship-poster/

Norman Davis sent a chat · 8:13 PM
No. I’ve joined before but I havent joined in a while. I’m just listening tonight

Norman Davis sent a chat · 8:19 PM
Question is this  a call I should be on. I did have treatment 3 yrs ago

Norman Davis sent a chat · 8:20 PM
ok thanks

AnCan – Boykin sent a chat · 8:23 PM
@Norman Davis – I would stay and listen in. It doesn’t hurt and you are already here.

Norman Davis sent a chat · 8:23 PM
Gotcha. I  dont have a reoccurrence

Bill Franklin sent a chat · 8:31 PM
bfranklin@ancan.org

AnCan – Rick sent a chat · 8:49 PM
2nd Opinions for MRIs  Botimage AI for MRIs: https://botimageai.com/prostatid/ ~$250, can also be used for biopsy targeting guidance  NIH 2nd Opinion MRI (no fees): Choyke, Peter (NIH/NCI) Radiologist pchoyke@mail.nih.gov  Second opinion of MRI from Johns Hopkins Images and Reports for Providers | Johns Hopkins Radiology (hopkinsmedicine.org) Email: eradiologycenter@jhmi.edu Phone: 443-287-7378 Fax: 443-769-1210  -Accolade Radiology NY, PA https://accoladeradiology.com/mritap.html  Radiology Check (Switzerland) https://radiologycheck.com/en

AnCan – Rick sent a chat · 8:51 PM
Bx 2nd Opinions       Ep-stine! Dr. Jonathan Epstein – https://advanceduropathology.com/ Tel: 516-760-2037 jepstein@imppllc.com

AnCan – Rick sent a chat · 8:52 PM
Dr. Ming Zhou Mount Sinai Health System Department of Pathology, Box 1194 Annenberg Bldg. 15th FL 1468 Madison Ave New York, NY 10029 Email: Ming.zhou@mountsinai.org Telephone: (212)241-8881

Steve in Malaysia sent a chat · 8:58 PM
I need to head out at 10ish (5 minutes). I’ll followup with Rick and Stuart re: how to think about negotiating costs … I was quoted $100k for HDR and $180k for MR Linac.

Steve in Malaysia sent a chat · 9:01 PM
Also wanted to thank you guys (Rick, Stuart and company) on all your help on this crazy journey… could never had ended up where I did without your help 🙂

AnCan – Rick sent a chat · 9:04 PM
You need to make sure it registers with the Lead Mod.

Clyde sent a chat · 9:07 PM
Hey gang.  Gotta run.  I am graduating to the high risk group, so I will see some of you there.

AnCan – Boykin sent a chat · 9:08 PM
@clyde – Good luck. We will miss you in low/intermediate.

Bob Richards sent a chat · 9:09 PM
I would like to update the group tonight on my situation if possible

Norman Davis sent a chat · 9:21 PM
Good questions. I’ll rejoin next week. Thanks

AnCan – Boykin sent a chat · 9:23 PM
Good night Norman!

AnCan – Boykin sent a chat · 9:26 PM
Nice dog George!

David in Portland, OR sent a chat · 9:40 PM
Prostate Cancer Free Foundation Intermediate Risk graph: https://www.prostatecancerfree.org/compare-prostate-cancer-treatments-intermediate-risk/  High Risk graph: https://www.prostatecancerfree.org/compare-prostate-cancer-treatments-high-risk/

David in Portland, OR sent a chat · 9:41 PM
Prostate Cancer Free Foundation Low Risk graph: https://www.prostatecancerfree.org/compare-prostate-cancer-treatments-low-risk/

George in NC sent a chat · 10:04 PM
Thank you all and good night!  See you in 2 weeks!   Very grateful to AnCan especailly Rick and Stuart!

Larry (Alaska Vet) sent a chat · 10:05 PM
David, can you put a link to that 2024 study also, please?

Bill Franklin sent a chat · 10:05 PM
Good night George.

AnCan – Boykin sent a chat · 10:05 PM
Good night George

Steve in Malaysia sent a chat · 10:06 PM
back

David in Portland, OR sent a chat · 10:18 PM
Albert Chang & Peter Rossi brachytherapy video lecture: https://www.youtube.com/watch?v=QkfB5kkOsm4

[Waiting for name] sent a chat · 10:21 PM
Hi Leon here, trying to get back wit ya. Hit the wrong button

David in Portland, OR sent a chat · 10:22 PM
A Randomized Trial Comparing Quality of Life after Low-Dose Rate or High-Dose Rate Prostate Brachytherapy Boost with Pelvic External Beam Radiation (Crook, Juanita), 2024: https://www.redjournal.org/article/S0360-3016(24)00381-X/fulltext

David in Portland, OR sent a chat · 10:23 PM
A Randomized Comparison of High-Dose-Rate and Low-Dose Rate Prostate Brachytherapy Combined with External Beam Radiation Therapy for Unfavorable Prostate Cancer: Efficacy Results After Median Follow-Up of 74 Months (Crook, Juanita), 2025: https://www.redjournal.org/article/S0360-3016(25)00303-7/abstract

David in Portland, OR sent a chat · 10:24 PM
HDR Brachytherapy Combined with External Beam Radiotherapy for Unfavorable Localized Prostate Cancer: A Single Center Experience from Inception to Standard of Care (Crook, Juanita), 2025: https://www.brachyjournal.com/article/S1538-4721(25)00004-2/fulltext